RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Income before tax

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.9B
P/E ratio
SummaryFinancials
Period EndIncome before tax (Million USD)YoY (%)
Dec 31, 2024-460+37.76%
Dec 31, 2023-334+29.45%
Dec 31, 2022-258+785.09%
Dec 31, 2021-29-82.86%
Dec 31, 2020-170-149.03%
Dec 31, 2019347-555.34%
Dec 31, 2018-76+227.19%
Dec 31, 2017-23-72.17%
Dec 31, 2016-84-4.87%
Dec 31, 2015-88+61.62%
Dec 31, 2014-54-18.28%
Dec 31, 2013-67-10.76%
Dec 31, 2012-75-12.03%
Dec 31, 2011-85

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)